Jérémy Jové

858 total citations
45 papers, 504 citations indexed

About

Jérémy Jové is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Jérémy Jové has authored 45 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 7 papers in Hepatology. Recurrent topics in Jérémy Jové's work include Prostate Cancer Treatment and Research (11 papers), Colorectal Cancer Treatments and Studies (9 papers) and Radiopharmaceutical Chemistry and Applications (6 papers). Jérémy Jové is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Colorectal Cancer Treatments and Studies (9 papers) and Radiopharmaceutical Chemistry and Applications (6 papers). Jérémy Jové collaborates with scholars based in France, Belgium and Japan. Jérémy Jové's co-authors include Nicholas Moore, R. Lassalle, C. Droz‐Perroteau, Patrick Blin, Annie Fourrier‐Réglat, Philip Robinson, C. Dureau‐Pournin, Pernelle Noïze, Sinem Ezgi Gülmez and Bruno Brochet and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and European Heart Journal.

In The Last Decade

Jérémy Jové

41 papers receiving 494 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jérémy Jové France 13 90 88 62 59 59 45 504
Hee Youn Choi South Korea 15 174 1.9× 74 0.8× 89 1.4× 42 0.7× 36 0.6× 40 1.0k
R J Spooner United Kingdom 16 125 1.4× 67 0.8× 139 2.2× 53 0.9× 23 0.4× 45 903
Daria Orszulak–Michalak Poland 13 68 0.8× 118 1.3× 81 1.3× 32 0.5× 27 0.5× 67 755
Elisabeth Bronder Germany 17 105 1.2× 47 0.5× 25 0.4× 24 0.4× 20 0.3× 24 807
B.G. Ellis United Kingdom 14 117 1.3× 145 1.6× 26 0.4× 64 1.1× 31 0.5× 17 652
T. Rietveld Netherlands 18 95 1.1× 110 1.3× 99 1.6× 28 0.5× 17 0.3× 36 973
Eva M. van Soest Netherlands 16 87 1.0× 219 2.5× 43 0.7× 58 1.0× 51 0.9× 28 916
Lucy Yang United States 15 27 0.3× 91 1.0× 109 1.8× 87 1.5× 20 0.3× 27 895
Ming‐Liang Lai Taiwan 11 135 1.5× 69 0.8× 72 1.2× 15 0.3× 25 0.4× 19 725

Countries citing papers authored by Jérémy Jové

Since Specialization
Citations

This map shows the geographic impact of Jérémy Jové's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérémy Jové with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérémy Jové more than expected).

Fields of papers citing papers by Jérémy Jové

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jérémy Jové. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérémy Jové. The network helps show where Jérémy Jové may publish in the future.

Co-authorship network of co-authors of Jérémy Jové

This figure shows the co-authorship network connecting the top 25 collaborators of Jérémy Jové. A scholar is included among the top collaborators of Jérémy Jové based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jérémy Jové. Jérémy Jové is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blin, Patrick, et al.. (2025). Comparative effectiveness of robot-assisted vs. open prostatectomy: a real-life nationwide study. World Journal of Urology. 43(1). 367–367. 1 indexed citations
2.
Gouverneur, Amandine, Jérémy Jové, Francesco Salvo, et al.. (2023). Impact of Cardiovascular Comorbidities on the Effectiveness and Safety of Bevacizumab in Older Patients with Metastatic Colorectal Cancer. Targeted Oncology. 18(5). 717–726.
3.
Jové, Jérémy, Marine Gross‐Goupil, Patrick Blin, et al.. (2023). Clustering of prostate cancer healthcare pathways in the French National Healthcare database. SHILAP Revista de lepidopterología. 2(1). 52–64. 5 indexed citations
4.
Blin, Patrick, N Danchin, C. Dureau‐Pournin, et al.. (2022). Should dual antiplatelet therapy be maintained beyond one year after a myocardial infarction? A cohort study within the French SNDS nationwide claims database. European Heart Journal. 43(Supplement_2).
5.
Bosco‐Lévy, Pauline, Angela Grelaud, Meritxell Sabidó, et al.. (2021). Incidence and risk of cancer among multiple sclerosis patients: A matched population‐based cohort study. European Journal of Neurology. 29(4). 1091–1099. 17 indexed citations
6.
Thurin, Nicolas H., Jérémy Jové, Xavier Rébillard, et al.. (2020). Changes in therapeutic strategy in metastatic castration resistant prostate cancer (mCRPC) between 2012 and 2014 from the French nationwide claims database (SNDS). European Urology Open Science. 19. e901–e901. 1 indexed citations
7.
Peleteiro, Paula, I. Henrı́quez, Antonio J. Conde-Moreno, et al.. (2020). Age, Gleason Score, and PSA are important prognostic factors for survival in metastatic castration-resistant prostate cancer. Results of The Uroncor Group (Uro-Oncological Tumors) of the Spanish Society of Radiation Oncology (SEOR). Clinical & Translational Oncology. 22(8). 1378–1389. 14 indexed citations
8.
Bosco‐Lévy, Pauline, et al.. (2019). Pharmacological treatment patterns in heart failure: a population-based cohort study. European Journal of Clinical Pharmacology. 76(1). 97–106. 3 indexed citations
9.
Oudard, Stéphane, Florence Joly, Karim Fizazi, et al.. (2019). Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort. British Journal of Cancer. 121(12). 1001–1008. 29 indexed citations
10.
Blin, Patrick, C. Dureau‐Pournin, Jacques Bénichou, et al.. (2018). Secondary prevention of acute coronary events with antiplatelet agents (SPACE-AA): One-year real-world effectiveness and safety cohort study in the French nationwide claims database. Atherosclerosis. 281. 98–106. 11 indexed citations
11.
François, Éric, António Sá Cunha, Alain Monnereau, et al.. (2018). Effectiveness of Cetuximab as First-Line Therapy for Patients With Wild-Type KRAS and Unresectable Metastatic Colorectal Cancer in Real-Life Practice: Results of the EREBUS Cohort. Clinical Colorectal Cancer. 17(2). 129–139. 14 indexed citations
12.
Bosco‐Lévy, Pauline, Jérémy Jové, Philip Robinson, et al.. (2016). Persistence to 5-year hormonal breast cancer therapy: a French national population-based study. British Journal of Cancer. 115(8). 912–919. 20 indexed citations
13.
Blin, Patrick, C. Dureau‐Pournin, R. Lassalle, et al.. (2016). Outcomes, Health Care Resources Use, And Costs In Patients With Post-Myocardial Infarction: The Horus Cohort Study In The Egb French Claims And Hospital Database. Value in Health. 19(3). A16–A16. 2 indexed citations
14.
Grelaud, Angela, Annie Fourrier‐Réglat, Olivier Fitoussi, et al.. (2015). Patterns and effectiveness of bortezomib use according to age in the VESUVE cohort. Leukemia & lymphoma. 57(6). 1349–1354. 4 indexed citations
15.
Dureau‐Pournin, C., Jean‐Michel Pedespan, C. Droz‐Perroteau, et al.. (2013). Continuation rates of levetiracetam in children from the EULEVp cohort study. European Journal of Paediatric Neurology. 18(1). 19–24. 4 indexed citations
16.
Fourrier‐Réglat, Annie, Pernelle Noïze, Thierry Façon, et al.. (2013). Real-life patterns of use and effectiveness of bortezomib: the VESUVE cohort study. Leukemia & lymphoma. 55(4). 848–854. 9 indexed citations
17.
Gülmez, Sinem Ezgi, Nicholas Moore, Georges‐Philippe Pageaux, et al.. (2013). Causality of Drugs Involved in Acute Liver Failure Leading to Transplantation: Results from the Study of Acute Liver Transplant (SALT). Drug Safety. 36(9). 757–764. 7 indexed citations
18.
Berke, Bénédicte, Catherine Chèze, Raphaële Le Garrec, et al.. (2012). Preventive and curative effect of Trigonella foenum-graecum L. seeds in C57BL/6J models of type 2 diabetes induced by high-fat diet. Journal of Ethnopharmacology. 142(2). 516–522. 53 indexed citations
19.
Droz‐Perroteau, C., C. Dureau‐Pournin, Hervé Vespignani, et al.. (2010). The EULEV cohort study: rates of and factors associated with continuation of levetiracetam after 1 year. British Journal of Clinical Pharmacology. 71(1). 121–127. 7 indexed citations
20.
Costa, B, et al.. (1991). Evaluación multicéntrica de un programa de diabetes en la atención primaria de Tarragona. Atención Primaria. 8(1). 22–29. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hee Youn Choi Breakdown of academic impact, for papers by R J Spooner Breakdown of academic impact, for papers by Daria Orszulak–Michalak Breakdown of academic impact, for papers by Elisabeth Bronder Breakdown of academic impact, for papers by B.G. Ellis Breakdown of academic impact, for papers by T. Rietveld Breakdown of academic impact, for papers by Eva M. van Soest Breakdown of academic impact, for papers by Lucy Yang Breakdown of academic impact, for papers by Ming‐Liang Lai
Rankless by CCL
2026